Index removals put PACS Group back in focus

PACS Group (PACS) has been removed from several Russell value benchmarks, including the Russell 2000 and related indices, an index reshuffle that can influence trading flows and short term volatility.

For investors tracking PACS Group, the index changes highlight a fresh reason to look at the stock’s fundamentals rather than just its benchmark affiliations, especially given its role in skilled nursing and senior care facilities.

Despite the index removals, PACS Group’s share price has shown strong recent momentum, with a 30 day share price return of 25.52% and a 1 year total shareholder return of very large magnitude from a much lower base. The latest move leaves the stock at US$44.02 and suggests sentiment has improved rather than faded.

If this kind of sharp move has you thinking about where else capital is rotating, it could be a good moment to scan for other potential opportunities using our 19 top founder-led companies

After a jump like PACS Group’s, now removed from value indices yet trading at US$44.02 with some implied upside to analyst targets, does the current valuation still leave enough reward to justify the risk for new buyers?

Most Popular Narrative: 11.4% Undervalued

Based on the most followed narrative, PACS Group’s fair value sits at $49.67, above the current $44.02 share price, which frames the recent rally in a different light.

Systematic improvement of newly acquired and turnaround facilities from low single digit margins toward the high single digit and low double digit margin profile of mature sites should unlock embedded profitability, lifting consolidated net margins and EBITDA over time.

Curious what kind of revenue growth, margin expansion and future earnings multiple have to line up for PACS Group to support that higher fair value? The full narrative spells out the specific growth path, the profitability step up across its 36,000 bed footprint, and the earnings profile that underpins analysts’ upgraded models, but keeps the exact mix of assumptions under the hood until you read it in detail.

Result: Fair Value of $49.67 (UNDERVALUED)

However, PACS Group’s story also hinges on the successful integration of more than 100 recently acquired facilities and on stable Medicaid and reimbursement frameworks in key states, which may not play out as analysts expect.

Next Steps

With sentiment on PACS Group split between upside potential and meaningful risks, take a moment to review the full picture and form your own view using the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond PACS Group?

If PACS Group has sharpened your focus, do not stop there. Broaden your watchlist with other stocks that fit clear, transparent criteria using targeted screeners.

• Target potential mispricings by scanning for companies that combine quality with attractive valuations through the 44 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies offering robust payouts using the 9 dividend fortresses.
• Tighten your risk profile by concentrating on companies with steadier characteristics via the 72 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.